Functional delineation of hyperprolactinemic-amenorrhea.
D000236:Adenoma / Q000378:metabolism / Q000601:surgery; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy / Q000378:metabolism*; D000728:Androgens / Q000097:blood; D001971:Bromocriptine / Q000627:therapeutic use; D004298:Dopamine / Q000494:pharmacology; D004967:Estrogens / Q000097:blood; D005260:Female; D005687:Galactorrhea / Q000378:metabolism; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D006065:Gonadotropins, Pituitary / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007980:Levodopa / Q000494:pharmacology; D010911:Pituitary Neoplasms / Q000378:metabolism / Q000601:surgery; D011247:Pregnancy; D011388:Prolactin / Q000097:blood*; D013972:Thyrotropin / Q000097:blood; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology
D000728:Androgens; D004967:Estrogens; D006065:Gonadotropins, Pituitary; D007987:Gonadotropin-Releasing Hormone; D001971:Bromocriptine; D007980:Levodopa; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D013972:Thyrotropin; D004298:Dopamine; D006854:Hydrocortisone